DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge

被引:27
作者
Isaguliants, MG
Petrakova, N
Zuber, B
Pokrovskaya, K
Gizatullin, R
Kostyuk, DA
Kjerrström, A
Winberg, G
Kochetkov, SN
Hinkula, J
Wahren, B [1 ]
机构
[1] Karolinska Inst, Swedish Inst Infect Dis Control, S-17182 Stockholm, Sweden
[2] Karolinska Inst, Microbiol & Tumorbiol Ctr, S-17182 Stockholm, Sweden
[3] WA Engelgardt Inst Mol Biol, Moscow, Russia
[4] DI Ivanovskii Virol Inst, Moscow 123098, Russia
关键词
HIV-1; protection; DNA vaccine; reverse transcriptase; mouse model;
D O I
10.1159/000053996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The present study was undertaken to examine the immunogenicity of a single plasmid DNA representing the reverse transcriptase (RT) of HIV-1. Plasmids containing the enzymatically active RT as well as a mutated nonenzymatically active RT with nucleotide (nt)-binding motifs of YMDD and YMLL, respectively, were used to immunize mice. Both constructs induced similar good antibody and T cell responses, with a tendency towards antibody directed to peptides representing the active and mutated sites. immunized mice were challenged with a murine pseudotype HIV-1/MuLV infected spleen cells. Seven out of 10 mice immunized with RT had no recoverable HIV-1, while 10 individuals immunized with the RT mutant and all the 18 controls had high levels of recoverable HIV-1. This indicates that mutation of RT reduces the desired immunogenicity. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:288 / 293
页数:6
相关论文
共 23 条
[1]   Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model [J].
Andäng, M ;
Hinkula, J ;
Hotchkiss, G ;
Larsson, S ;
Britton, S ;
Wong-Staal, F ;
Wahren, B ;
Ährlund-Richter, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12749-12753
[2]   IDENTIFICATION OF THE PRIMER BINDING DOMAIN IN HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE [J].
BASU, A ;
AHLUWALIA, KK ;
BASU, S ;
MODAK, MJ .
BIOCHEMISTRY, 1992, 31 (02) :616-623
[3]  
DESAI DD, 1993, J IMMUNOL, V151, P1614
[4]   ISOLATION OF AN ACTIVE HUMAN TRANSPOSABLE ELEMENT [J].
DOMBROSKI, BA ;
MATHIAS, SL ;
NANTHAKUMAR, E ;
SCOTT, AF ;
KAZAZIAN, HH .
SCIENCE, 1991, 254 (5039) :1805-1808
[5]  
GOFF SP, 1990, J ACQ IMMUN DEF SYND, V3, P817
[6]   L1 FAMILY OF REPETITIVE DNA-SEQUENCES IN PRIMATES MAY BE DERIVED FROM A SEQUENCE ENCODING A REVERSE TRANSCRIPTASE-RELATED PROTEIN [J].
HATTORI, M ;
KUHARA, S ;
TAKENAKA, O ;
SAKAKI, Y .
NATURE, 1986, 321 (6070) :625-628
[7]   Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes [J].
Hinkula, J ;
Svanholm, C ;
Schwartz, S ;
Lundholm, P ;
Brytting, M ;
Engstrom, G ;
Benthin, R ;
Glaser, H ;
Sutter, G ;
Kohleisen, B ;
Erfle, V ;
Okuda, K ;
Wigzell, H ;
Wahren, B .
JOURNAL OF VIROLOGY, 1997, 71 (07) :5528-5539
[8]  
ISAGULIANTS M, 1999, 4 EUR C EXP AIDS RES, P71
[9]   Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase [J].
Isaguliants, MG ;
Pokrovskaya, K ;
Kashuba, VI ;
Pokholok, D ;
Hinkula, J ;
Wahren, B ;
Kochetkov, SN .
FEBS LETTERS, 1999, 447 (2-3) :232-236
[10]   Immunogenic properties of reverse transcriptase of HIV type 1 assessed by DNA and protein immunization of rabbits [J].
Isaguliants, MG ;
Gudima, SO ;
Ivanova, OV ;
Levi, M ;
Hinkula, J ;
Garaev, MM ;
Kochetkov, SN ;
Wahren, B .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (13) :1269-1280